The Global Breast Cancer Screening Tests Market Is Fueled By Advancing Imaging Technologies And Biomarker Testing, With A Projected Remarkable CAGR Of 7.8% By 2033 | Future Market Insights, Inc.
July 26, 2023 12:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, July 26, 2023 (GLOBE NEWSWIRE) -- Future Market Insights' latest Global Breast Cancer Screening Tests Market study reveals promising growth prospects. Factors such as an aging...
Mammography Systems Market (Product, Technology) – Reach $3.79 Billion by 2027 at 7.4% CAGR with 3D Mammograph Segment Driving Growth During 2020-2027 | The Insight Partners
June 07, 2023 07:34 ET
|
The Insight Partners
Pune, India, June 07, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Mammography Systems Market Share Report, Share, Revenue, Growth Strategy, Industry Trends and...
Ionizing Breast Imaging Technologies Most Crucial in Breast Cancer Diagnosis: Fact.MR Report
September 19, 2022 05:05 ET
|
FACT.MR
Dublin, Ireland, Sept. 19, 2022 (GLOBE NEWSWIRE) -- According to a new study by Fact.MR, a market research and competitive intelligence provider, the global demand for breast imaging technologies is...
Breast Cancer Screening Market Size to Reach US$ 4.48 billion by 2030| Exclusive Report by Growth Plus Reports
August 18, 2022 06:08 ET
|
Growth Plus Reports
Pune, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The global breast cancer screening market is expected to reach US$ 4.48 billion by 2030. The screening procedure is a promising option for early breast cancer...
Todos Medical Announces Publication Demonstrating Potential of FTIR Platform to Identify Bacterial and Viral Infections
March 02, 2020 08:50 ET
|
Todos Medical Ltd.
Todos evaluating applying its proprietary FTIR platform towards the novel coronavirusSeeking appropriate partners to get access to patient samples to train its AI platform REHOVOT, Israel and NEW...
Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing
February 25, 2020 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Receives Notice of Allowance from European Patent Office Covering Diagnosis of Solid Tumors Using AI to Analyze Blood
February 19, 2020 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Releases Letter to Shareholders
February 07, 2020 09:15 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes
January 09, 2020 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos To Present At Upcoming 12th Annual LD Micro Main Event
December 06, 2019 07:29 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...